Friday, October 5, 2018: 12:30 PM-1:45 PM
Room: S Poster Hall
Tracks: Pediatric ID, Investigative ID, Adult ID
Presentations:
Clinical implications of emerging nonvaccine-serotype invasive pneumococcal disease among adults in the Republic of Korea in the era of protein conjugated pneumococcal vaccine
Jong Hun Kim, MD;
Seung Hee Baik, MD;
Joon Young Song, MD;
In-Gyu Bae, MD;
Hyo Youl Kim, MD, PhD;
Dong-Min Kim, MD;
Young Hwa Choi, MD, PhD;
Won Suk Choi, MD, PhD;
Y.H. Jeong, MD;
Hyun Hee Kwon, M.D;
Hye Won Jeong, M.D. Ph.D.;
Yeon-Sook Kim, MD;
Jeong Yeon Kim, M.D., Ph.D.;
Jacob Lee, M.D.;
Sae Yoon Kee, MD;
Jin-Won Chung, MD;
Moon H. Nahm, MD;
Min-Ja Kim, MD., Ph.D
VENOUS 1: A Prospective Multicenter Cohort Study of Enterococcal Bacteremia
German Contreras, MD MSc;
Jose M Munita, MD;
Katherine C. Reyes, MD, MPH;
Pranoti Sahasrabhojane, MS;
Helina Misikir, MPH;
Heather Garza, MSc;
Marcus J Zervos, MD;
Samuel L. Aitken, PharmD;
Samuel A. Shelburne, MD, PhD;
Cesar Arias, MD, PhD, FIDSA
Sepsis and secondary hemophagocytic lymphohistiocytosis
Farhan Fazal, MBBS, MD;
Naveet Wig, MD;
Manish Soneja, MD Medicine;
Dipendra K Mitra, MD;
Sk Panda, MD;
Gita Satpathy, MD;
Naval Kishore Vikram, MD;
R.M Pandey, MD;
P.K Chaturvedi, MD
BLOODSTREAM INFECTION SURVEY in HIGH-RISK ONCOLOGY PATIENTS (BISHOP) with FEVER AND NEUTROPENIA (FN): Predictors for Morbidity and Mortality
Alison G. Freifeld, MD;
Andrea Zimmer, MD;
Christopher Arnold, MD;
John W. Baddley, MD;
Pranatharthi Chandrasekar, MD;
Zeinab El Boghdadly, MBBCh;
Eileen K. Maziarz, MD;
Jose G. Montoya, MD, FIDSA;
Steven Pergam, MD, MPH, FIDSA;
Kenneth V. Rolston, MD;
Gowri Satyanarayana, MD;
Shmuel Shoham, MD;
Lynne Strasfeld, MD;
Randy Taplitz, MD;
Thomas J. Walsh, MD, PhD;
Jo-Anne Young, MD;
Yuning Zhang, Ph.D;
Jane Meza, PhD
Prevalence of bacteremia/fungemia and pneumonia in remission induction chemotherapy for adult acute myeloid leukemia from 1987 to 2005: Japan Adult Leukemia Study Group (JALSG).
Hideaki Kato, MD;
Hiroyuki Fujita, MD;
Nobu Akiyama, MD;
Shun-Ichi Kimura, MD;
Nobuhiro Hiramoto, MD;
Naoko Hosono, MD;
Tsutomu Takahashi, MD;
Kazuyuki Shigeno, MD;
Hitoshi Minamiguchi, MD;
Junichi Miyatake, MD;
Hiroshi Handa, MD;
Yoshinobu Kanda, MD;
Minoru Yoshida, MD;
Shuichi Miyawaki, MD;
Shigeki Ohtake, MD;
Tomoki Naoe, MD;
Hitoshi Kiyoi, MD;
Itaru Matsumura, MD;
Yasushi Miyazaki, MD
Injection Drug Use-associated Staphylococcus aureus Bacteremia in a Large Urban Hospital in Atlanta, Georgia
David P. Serota, MD;
Colleen Kelley, MD, MPH;
Jesse T. Jacob, MD;
Susan M. Ray, MD, FIDSA;
Marcos C. Schechter, MD;
Russell Kempker, M.D., M.Sc.
A controlled-release prescription oral opioid can prolong S. aureus survival in injection drug preparation equipment and potentially increase bacteremia risk
Katherine Kasper, PhD;
Iswarya Manoharan, MD;
Dresden Glockler-Lauf, MPH;
Laura Ball, BSc, MPH;
Brian Hallam, BA;
Sharon Koivu, MD;
John McCormick, PhD;
Michael Silverman, MD, FRCP, FACP
First Episode Infective Endocarditis in Persons Who Inject Drugs (PWIDs); a retrospective cohort study
Laura Rodger, MD;
Dresden GlockerLauf, MPH;
Esfandiar Shojaei, MD;
Adeel Sherazi, MD;
Brian Hallam, BA;
Laura Ball, BSc, MPH;
Sharon Koivu, MD;
Kaveri Gupta, MD, FRCP;
Seyed Hosseini-Moghaddam, MD;
Michael Silverman, MD, FRCP, FACP
Trends in Infective Endocarditis During the Substance Use Disorder Epidemic at an Academic Medical Center
Craig A. Martin, PharmD, MBA;
Donna R. Burgess, RPh;
Katie L. Wallace, PharmD, BCPS;
Jeremy Vanhoose, PharmD, BCPS;
Sarah Cotner, PharmD, BCPS;
David S. Burgess, PharmD, FCCP, FIDP
Nationwide Temporal Trends of Candidemia Incidence over 18 Years within the Veteran Health Administration System
Hiroyuki Suzuki, MD;
Eli Perencevich, MD, MS, FIDSA, FSHEA;
Daniel Diekema, MD, FIDSA, FSHEA;
Daniel Livorsi, MD, MSc;
Marin Schweizer, PhD;
Rajeshwari Nair, PhD, MBBS, MPH;
Michael Ohl, MD MSPH;
Kelly Richardson, PhD;
Brice Beck, MA;
Bruce Alexander, PharmD;
Michihiko Goto, MD, MSCI
Thinking Outside the Bowel - Clostridium difficile Bacteremia Case Series
Adam Pettigrew, MD;
Ripal Jariwala, PharmD;
Kristen Zeitler, PharmD;
Jose Montero, MD, FACP, FIDSA;
Sandra Gompf, MD, FIDSA;
John Toney, MD, FACP, FIDSA
Whole Genome Sequencing Analysis of a Large Cohort of Staphylococcus epidermidis Blood Culture Positive Isolates from a Multicenter Clinical Trial
Rita Wilson Dib, MD;
Xiqi Li, MS;
Samuel Shelburne, MD, PhD, FIDSA;
Anne-Marie Chaftari, MD;
Ray Y. Hachem, MD;
Ruth Reitzel, PhD;
Nylev Vargas-Cruz, BS;
Thomas L. Holland, MD;
Vance G. Fowler Jr., MD;
Issam Raad, MD
Evaluation of Early Clinical Failure Criteria for Gram-Negative Bloodstream Infections
Hana Rac, PharmD;
Alyssa Gould, PharmD;
P. Brandon Bookstaver, PharmD, FCCP, FIDSA, BCPS, AAHIVP;
Julie Ann Justo, PharmD, MS;
Joseph Kohn, PharmD, BCPS;
Majdi N. Al-Hasan, MBBS
Do Healthcare Providers De-Escalate Beta-lactam (BL) Antibiotic Therapy Based on Results of Antibiotic Susceptibility Testing (AST)? Analysis of Bloodstream Infections (BSI) Caused by Escherichia coli (Ec) and Klebsiella pneumoniae (Kpn) from the Veterans Health Administration (VHA)
Roberto Viau, MD;
Brigid Wilson, PhD;
Scott R. Evans, PhD;
Federico Perez, MD, MS;
Vance G. Fowler Jr., MD;
Henry F. Chambers, MD;
Barry N. Kreiswirth, PhD;
Robin Patel, MD, FIDSA, D(ABMM);
Ritu Banerjee, MD, PhD;
Robert A. Bonomo, MD
Epidemiology and Mechanisms of Carbapenem Resistance in Recurrent Extended-Spectrum β-lactamase- Producing Enterobacteriaceae Bacteremia
Samuel L. Aitken, PharmD;
Micah Bhatti, MD, PhD;
Pranoti Sahasrabhojane, MS;
Jessica Galloway-Pena, PhD;
Xiqi Li, MS;
Frank P. Tverdek, PharmD;
Cagney Reeves, PharmD;
Patrick McDaneld, PharmD;
David Greenberg, MD, FIDSA;
Samuel Shelburne, MD, PhD, FIDSA
Predicting central nervous system complications in Staphylococcus aureus bacteremia using clinical scoring system
Chung-Jong Kim, MD, PhD;
Kyoung-Ho Song, M.D., Ph.D.;
Chang Kyung Kang, MD;
Pyeong Gyun Choe, M.D.;
Ji Yun Bae, MD;
Hee Jung Choi, MD;
Younghee Jung, MD;
Seung Soon Lee, MD;
Wan Beom Park, M.D., Ph.D;
Ji Hwan Bang, M.D.;
Eu Suk Kim, PhD;
Sang Won Park, M.D., Ph.D.;
Nam Joong Kim, M.D., Ph.D.;
Myoung-Don Oh, M.D., Ph.D.;
Hong Bin Kim, M.D., Ph.D.
Prognostic Biomarkers for Persistent Bacteremia and Mortality in Complicated S. aureus Bloodstream Infection
Yi Cao, PhD;
Alessander Guimaraes, PhD;
Kyu Hong, PhD;
Oleg Mayba, phD;
Melicent Peck, MD, PhD;
Johnny Gutierrez, PhD;
Felicia Ruffin, MSN, RN;
Montserrat Carrasco-Triguero, PhD;
Jason Dinoso, PhD;
A Asa Clemenzi-Allen, MD;
Catherine Koss, PhD;
Stacey A. Maskarinec, MD, PhD;
Henry F. Chambers, MD;
Vance G. Fowler Jr., MD;
Amos Baruch, PhD;
Carrie Rosenberger, PhD
Staphylococcus aureus bacteremia treatment: results from pilot surveillance in four US states.
Sarah Kabbani, MD MSc;
Kelly Jackson, MPH;
Lauren Epstein, MD, MSc;
Anita Gellert, RN;
Carmen Bernu, BS;
Rahsaan Overton, MPH;
Joelle Nadle, MPH;
Ghinwa Dumyati, MD, FSHEA;
Ruth Lynfield, MD, FIDSA;
Susan M. Ray, MD;
Erin Epson, MD;
Isaac See, MD
Risk Factors for Recurrent Staphylococcus aureus Bacteremia
Seong-Ho Choi, MD, PhD;
Felicia Ruffin, MSN, RN;
Lawrence Park, PhD;
Batu K Sharma-Kuinkel, PhD;
Maria Souli, MD PhD;
Bobby Warren, MPS;
Brenda Hansen, M.S.;
Felix Mba Medie, PhD;
Vance G. Fowler Jr., MD
Comparison of the Acute Physiology and Chronic Health Evaluation (APACHE) II Score and the Pitt Bacteremia Score to Predict Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia
Sarah Jorgensen, PharmD, BCPS, AAHIVP;
Evan J. Zasowski, PharmD, MPH;
Trang D. Trinh, PharmD, MPH;
Abdalhamid M. Lagnf, MPH;
Sahil Bhatia, B.S.;
Michael J. Rybak, PharmD, MPH, PhD
Daptomycin/ceftaroline in combination versus vancomycin for the treatment of methicillin resistant Staphylococcus aureus bacteremia
Matthew Fox, PharmD Candidate;
Klarida Zeqollari, PharmD Candidate;
Grant Lee, PharmD Candidate;
Laura Pontiggia, PhD;
Dana Byrne, MD, MSCE;
Jessica Adams, PharmD, BCPS, AAHIVP;
Madeline King, Pharm D;
Lucia Rose, PharmD
Comparative Effectiveness of Nafcillin or Oxacillin, Cefazolin, and Piperacillin/tazobactam in Methicillin-Sensitive Staphylococcus aureus Bacteremia
Maya Beganovic, Pharm.D., MPH;
Jaclyn Cusumano, PharmD;
Vrishali Lopes, MS;
Kerry LaPlante, Pharm.D., FCCP, FIDSA;
Aisling Caffrey, PhD, MS
Evaluation of Cefazolin versus Anti-Staphylococcal Penicillins for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections in Acutely-Ill Adult Patients: Results of a Systematic Review and Meta-Analysis
Benjamin J. Lee, PharmD, BCPS;
Janie K. Constantino-Corpuz, PharmD Candidate;
Kristel Apolinario, PharmD Candidate;
Sheila K. Wang, PharmD, BCPS;
Barbara Nadler, MS;
Marc H. Scheetz, PharmD, MSc, BCPS AQ-ID;
Nathaniel J. Rhodes, PharmD, MSc, BCPS
Predictive Factors for Metastatic Infection in Patients with Bacteremia Caused by Staphylococcus aureus
Akihiro Shimizu, MD;
Tetsuya Horino, MD;
Yumiko Hosaka, MD;
Tokio Hoshina, MD;
Kazuhiko Nakaharai, MD;
Kwangyeol Lee, MD;
Makiko Miyajima, MD;
Yasushi Nakazawa, MD;
Masaki Yoshida, MD;
Hiroshi Yoshida, MD;
Seiji Hori, MD
Epidemiological and Clinical Features of Panton-Valenton Leukocidin Positive Staphylococcus aureus bacteremia: a Case-Control Study
Humera Kausar, MD;
Stephen Smith, BA;
Ming Da Qu, MD;
Peter G Lazar, BS;
Aimee Kroll-Desrosiers, MS;
Bruce Barton, PhD;
Doyle V Ward, PhD;
Richard T Ellison III, MD, FIDSA, FSHEA
Impact of Standard versus Prolonged Courses of Antibiotics for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia (SAB) in Patients with Hematologic Malignancies
Edna Cheung, PharmD;
Matt G. McKenzie, PharmD;
Lydia Benitez Colon, PharmD, BCOP;
Keith S. Kaye, MD, MPH;
Lindsay Petty, MD;
Emily T. Martin, MPH, PhD;
Bernard L. Marini, PharmD, BCOP;
Anthony J. Perissinotti, PharmD, BCOP;
Gregory Eschenauer, PharmD, BCPS;
Cesar Alaniz, PharmD;
Katie L. Wallace, PharmD, BCPS;
Twisha S. Patel, PharmD, BCPS
Streamlining to oral beta-lactam versus fluoroquinolone as definitive therapy for Enterobacteriaceae bacteremia
Karen Fong, PharmD, AAHIVP;
Yanina Dubrovskaya, PharmD, BCPS (AQ-ID), AAHIVP;
Justin Siegfried, PharmD, BCPS;
John Papadopoulos, BS, PharmD, FCCM, BCCCP, BCNSP;
Vinh Pham, MD, PhD;
Shin-Pung (Polly) Jen, PharmD, BCPS (AQ-ID), AAHIVP
Predictors of Vancomycin Switch or Escalation in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
Abdalhamid M. Lagnf, MPH;
Sarah Jorgensen, PharmD, BCPS, AAHIVP;
Evan J. Zasowski, PharmD, MPH;
Trang D. Trinh, PharmD, MPH;
Sahil Bhatia, B.S.;
Susan L Davis, PharmD;
Michael J. Rybak, PharmD, MPH, PhD
Management and Outcomes of Infective Endocarditis due to Nutritionally Variant Streptococci
Madiha Fida, MD;
Tarab Mansoor, MBBS;
Omar Abu Saleh, MD;
Ahmed Hamdi, MD;
Daniel C. Desimone, MD;
Walter R. Wilson, MD, FIDSA;
James Steckelberg, MD, FIDSA;
Larry M. Baddour, MD;
M. Rizwan Sohail, MD
Heart transplantation as salvage treatment for intractable infective endocarditis
Pierre Tattevin, MD, PHD;
Patricia Muñoz, PhD;
Asuncion Moreno, PhD;
Guillaume Hékimian, MD;
François Delahaye, MD, PhD;
Xavier Duval, MD, PhD;
María Ángeles Castel, MD;
Barbara Hasse, MD;
Natalia Jamarillo, MD;
Josip Vincelj, MD, PhD;
Dannah Wray, MD;
Carlos Mestres, MD, PhD;
Jose Miro, MD, PhD
Meta-Analysis of Survival Outcomes in People who Inject Drugs after Cardiac Surgery for Infective Endocarditis
David Goodman-Meza, MD, MAS;
Robert E. Weiss, PhD;
Sebastián Gamboa, MS;
Abel Gallegos, MS;
Raphael J. Landovitz, MD, MSc;
Alex A. T. Bui, PhD;
Matthew B. Goetz, MD;
Steven Shoptaw, PhD
Long-term prognosis of 448 Infectious Endocarditis followed by an Endocarditis team
Fabrice Camou, MD;
Carine Greib, MD;
Irène Machelart, MD;
Marina Dijos, MD;
Claire Cornolle, MD;
Laurent Barandon, MDPhD;
Olivia Peuchant, MD, PhD;
Gaetane Wirth, MD;
Nahema Issa, MD
Enterococcal Cardiac Implantable Electronic Device (CIED) Infections: Clinical Features and Outcomes.
Timothy S Oh, BS;
James E Peacock Jr., MD;
Katherine Le, MD;
M Rizwan Sohail, MD;
Larry M Baddour, MD;
Holenarasipur R Vikram, MD;
Jose M Miro, MD, PhD;
Jordan M Prutkin, MD, MHS;
Arnold J Greenspon, MD;
Roger G Carrillo, MD;
Stephan B Danik, MD;
Christoph K Naber, MD, PhD;
Elisabeth Blank, MD;
Chi-Hong Tseng, PhD;
Daniel Z Uslan, MD
Impact of Systematic Thoraco-Abdomino-Pelvic CT Scan on the Diagnosis of Infective Endocarditis
Raphaël Lecomte, PhD;
Nahema Issa, MD;
Paul Le Turnier, resident;
Benjamin Gaborit, MD;
Colin Deschanvres, MD;
Nathalie Asseray, MD, PhD;
Fabrice Camou, MD;
David Boutoille, MD, PhD
CME Credits: Maximum of 0.00 hours of
AMA PRA Category 1 Credit™
